| 期 |
栏目 |
标题 |
文件 |
| 卷 81, 编号 8 (2009) |
Editorial |
Clinical experience with infliximab administration in patients with rheumatoid arthritis by Russian register data |
|
| 卷 81, 编号 10 (2009) |
Editorial |
Relationship between the intima-media complex thickness, the risk factors of cardiovascular diseases, and the level of C-reactive protein in gouty patients |
|
| 卷 82, 编号 5 (2010) |
Editorial |
Rheumatic diseases: Current technologies and perspectives of laboratory diagnosis |
|
| 卷 82, 编号 5 (2010) |
Editorial |
New approaches to pharmacotherapy for rheumatoid arthritis: perspective for use of tocilizumab (monoclonal antibodies to interleukin-6 receptor) |
|
| 卷 82, 编号 6 (2010) |
Editorial |
The first experience in using rituximab in Mikulicz's disease |
|
| 卷 83, 编号 5 (2011) |
Editorial |
Perspectives of the treatment of rheumatic diseases in the beginning of the XXI century |
|
| 卷 83, 编号 5 (2011) |
Editorial |
Ten-year risk of cardiovascular complications in patients with rheumatoid arthritis |
|
| 卷 83, 编号 5 (2011) |
Editorial |
Current knowledge about pathogenesis and treatment of arterial hypertension in rheumatoid arthritis |
|
| 卷 84, 编号 5 (2012) |
Editorial |
RHEUMATOID ARTHRITIS: PROBLEMS AND SIGNIFICANCE OF PERSONALIZED MEDICINE |
|
| 卷 84, 编号 5 (2012) |
Editorial |
TOCILIZUMAB IMPACT ON BLOOD CHOLESTERINE TRANSPORT AND EARLY MANIFESTATION OF ATHEROSCLEROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS |
|
| 卷 84, 编号 5 (2012) |
Editorial |
FRAX-ASSISTED PREDICTION OF FRACTURES IN PATIENTS WITH RHEUMATOID ARTHRITIS |
|
| 卷 84, 编号 5 (2012) |
Editorial |
HCV-ASSOCIATED CRYOGLOBULINEMIC VASCULITIS |
|
| 卷 84, 编号 5 (2012) |
Editorial |
CURRENT TRENDS IN CLASSIFICATION AND TREATMENT OF SYSTEMIC VASCULITIS ASSOCIATED WITH ANTI-NEUTROPHILIC CYTOPLASMIC ANTIBODIES: RESULTS OF 2011 |
|
| 卷 90, 编号 5 (2018) |
Editorial |
Atherosclerosis: perspectives of anti-inflammatory therapy |
(Rus)
|
| 卷 90, 编号 5 (2018) |
Editorial |
Results of one-year treat-to-target strategy in early psoriatic arthritis: data of an open-label REMARCA study |
(Rus)
|
| 卷 90, 编号 5 (2018) |
Editorial |
Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases |
(Rus)
|
| 卷 90, 编号 5 (2018) |
Editorial |
Association of polymorphisms of HLA-DRB1 and TNF-308 G/A with radiographic joint damage in patients with early rheumatoid arthritis with high inflammatory activity, treated according to the principle of “Treat to target” (REMARKA study) |
(Rus)
|
| 卷 90, 编号 5 (2018) |
Editorial |
Efficacy and tolerability of abatacept treatment: results of 12 months observation |
(Rus)
|
| 卷 91, 编号 2 (2019) |
Editorial |
The use of Tofacitinib in the treatment of inflammatory bowel disease |
(Rus)
|
| 卷 91, 编号 5 (2019) |
Editorial |
Rheumatoid arthritis: achievements and unresolved issues |
(Rus)
|
| 卷 91, 编号 5 (2019) |
Editorial |
Chronic pain and depression in patients with rheumatoid arthritis: results of five - year follow - up |
(Rus)
|
| 卷 91, 编号 5 (2019) |
Editorial |
Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range |
(Rus)
|
| 卷 91, 编号 5 (2019) |
Editorial |
The role of laboratory biomarkers in monitoring of rituximab biosimilar therapy (Acellbia, “BIOCAD”) in patients with rheumatoid arthritis |
(Rus)
|
| 卷 91, 编号 5 (2019) |
Editorial |
The сhanges of bone mineral density on the risk of progression of osteoarthritis of the knee |
(Rus)
|
| 卷 91, 编号 8 (2019) |
Editorial |
New directions of pharmacotherapy of immune - inflammatory rheumatic diseases |
(Rus)
|
| 卷 92, 编号 5 (2020) |
Clinical notes |
Thrombotic microangiopathy in rheumatology: a link between thrombosis and autoimmunity |
(Rus)
|
| 卷 92, 编号 5 (2020) |
Original articles |
Mental disorders and cognitive impairment in patients with antiphospholipid syndrome |
(Rus)
|
| 卷 92, 编号 5 (2020) |
Original articles |
Advantages of therapy with sodium glucose cotransporter type 2 inhibitors in patients with type 2 diabetes mellitus in combination with hyperuricemia and gout |
(Rus)
|
| 卷 93, 编号 5 (2021) |
Editorial |
2019 Coronavirus disease (COVID-19): contribution of rheumatology |
(Rus)
|
| 卷 93, 编号 5 (2021) |
Original articles |
Influence of successful psychopharmacotherapy of anxiety-depressive spectrum disorders on the severity of chronic fatigue in patients with rheumatoid arthritis |
(Rus)
|
| 卷 93, 编号 5 (2021) |
Original articles |
Application of cardiovascular risk scales to identify carotid atherosclerosis in patients with rheumatoid arthritis |
(Rus)
|
| 卷 93, 编号 5 (2021) |
Original articles |
The relationship between obesity, cardiometabolic disorders and disease activity in psoriatic arthritis patients: data from the Russian register |
(Rus)
|
| 卷 93, 编号 5 (2021) |
Reviews |
Advantages of the use of metformin in patients with impaired uric acid metabolism |
(Rus)
|
| 卷 94, 编号 5 (2022) |
Editorial |
Janus kinase inhibitors in immunoinflammatory rheumatic diseases |
(Rus)
|
| 卷 94, 编号 5 (2022) |
Original articles |
Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis |
(Rus)
|
| 卷 94, 编号 5 (2022) |
Original articles |
The burden of progression of psoriatic arthritis. All-Russian register data |
(Rus)
|
| 卷 94, 编号 5 (2022) |
Original articles |
Antibodies to the phosphatidylserine/prothrombin complex in the diagnosis of antiphospholipid syndrome |
(Rus)
|
| 卷 94, 编号 5 (2022) |
Original articles |
Difficult-to-treat rheumatoid arthritis in real clinical practice. Preliminary results |
(Rus)
|
| 卷 94, 编号 8 (2022) |
Reviews |
Role of interleukin-1 in human diseases: pharmacotherapy prospects: A review |
(Rus)
|
| 卷 95, 编号 5 (2023) |
Editorial |
Systemic lupus erythematosus and antiphospholipid syndrome: past, present, future |
(Rus)
|
| 卷 95, 编号 5 (2023) |
Original articles |
Subclinical atherosclerosis of the carotid arteries in patients with rheumatoid arthritis with low cardiovascular risk |
(Rus)
|
| 卷 95, 编号 5 (2023) |
Original articles |
A new integral enthesial-comorbididity index of psoriatic arthritis activity |
(Rus)
|
| 卷 95, 编号 5 (2023) |
Original articles |
Comparative assessment of sensitivity and specificity of three variants of classification criteria for systemic lupus erythematosus in a cohort of Russian patients |
(Rus)
|
| 卷 95, 编号 5 (2023) |
Reviews |
Hypogonadism syndrome in men with inflammatory joint diseases: A review |
(Rus)
|
| 卷 95, 编号 12 (2023) |
Reviews |
Autoimmunity in rheumatology: A review |
(Rus)
|
| 卷 96, 编号 5 (2024) |
Original articles |
NETosis in lupus nephritis |
(Rus)
|
| 卷 96, 编号 5 (2024) |
Original articles |
The effect of hypothyroidism on cardiovascular events and type 2 diabetes mellitus developing in rheumatoid arthritis |
(Rus)
|
| 卷 96, 编号 5 (2024) |
Original articles |
Uric acid, cognitive disorders, neurodegeneration |
(Rus)
|
| 卷 96, 编号 5 (2024) |
Original articles |
Clinical and instrumental characteristics of psoriatic arthritis in men and women. Data from a cohort observational study |
(Rus)
|
